Efficacy and safety of ramucirumabcontaining chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma
Abstract Background Ramucirumab (RAM), a monoclonal antibody for vascular endothelial growth factor 2 (VEGFR2), has been effective for advanced gastric adenocarcinoma (AC). However, little is known about the efficacy of…